Hospital Corporation of China Ltd (3869) AI Stock Analysis

• Market Cap: HK$545.87M
• Dividend Yield: N/A
• Average Volume (3M): 660.00
• Price to Earnings (P/E): 5.0
• Beta (1Y): 0.10
• Revenue Growth: 2.30%
• EPS Growth: N/A
• Country: HK
• Employees: 1,841
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): -0.14
• Shares Outstanding: 138,194,000
• 10 Day Avg. Volume: 1,420
• 30 Day Avg. Volume: 660
• PEG Ratio: 0.18
• Price to Book (P/B): 2.59
• Price to Sales (P/S): 0.61
• P/FCF Ratio: 4.44
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 56 Neutral
• Price Target: HK$5.50 ▼(-5.17% Downside)
• Action: Reiterated Date: 10/31/25
• Date: Action: Reiterated 10/31/25

The overall stock score is primarily influenced by financial performance and technical analysis. The company's financial health is challenged by negative net income and liquidity concerns, while technical indicators show bearish momentum. The stock's low P/E ratio offers some valuation appeal, but the lack of dividend yield and earnings call data limits further insights.

Positive Factors

Consistent revenue growth

Sustained top-line growth, even if modest, indicates ongoing demand for the group’s clinical services and supports utilization gains across hospitals. Over the next 2–6 months this revenue trend underpins scale economics and provides a base for margin recovery and reinvestment in services.

Negative Factors

Negative net income and ROE

A net loss and negative return on equity erode shareholder capital and constrain retained earnings available for reinvestment. Persisting losses can exacerbate funding needs, weaken stakeholder confidence, and make it harder to deleverage or fund expansion without external capital over the medium term.

Hospital Corporation of China Ltd Business Overview & Revenue Model

Company Description

Hospital Corporation of China Limited, an investment holding company, engages in the operation and management of hospitals in the People's Republic of China. The company provides hospital management and consulting services to Yangsi Hospital, Cixi...

Read more

Hospital Corporation of China Limited, an investment holding company, engages in the operation and management of hospitals in the People's Republic of China. The company provides hospital management and consulting services to Yangsi Hospital, Cixi...

How the Company Makes Money

Hospital Corporation of China Ltd generates revenue primarily through its hospital operations, which include inpatient and outpatient services, diagnostic testing, and surgical procedures. The company earns money by charging patients for medical s...

Read more

Hospital Corporation of China Ltd generates revenue primarily through its hospital operations, which include inpatient and outpatient services, diagnostic testing, and surgical procedures. The company earns money by charging patients for medical s...

Hospital Corporation of China Ltd Financial Statement Overview

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.47B	1.44B	1.43B	1.14B	520.29M	399.21M
Gross Profit	270.25M	275.82M	239.36M	150.88M	214.23M	194.33M
EBITDA	220.71M	236.48M	283.48M	-464.44M	-401.87M	-379.86M
Net Income	133.81M	-38.63M	131.38M	-480.95M	-280.71M	-404.34M
Balance Sheet
Total Assets	2.55B	2.58B	2.50B	2.44B	3.12B	3.74B
Cash, Cash Equivalents and Short-Term Investments	723.01M	813.08M	667.89M	627.61M	779.97M	951.46M
Total Debt	1.02B	1.15B	1.04B	1.10B	1.09B	1.71B
Total Liabilities	1.82B	2.01B	1.91B	1.99B	1.99B	2.38B
Stockholders Equity	508.47M	337.71M	379.09M	255.71M	797.97M	1.08B
Cash Flow
Free Cash Flow	150.95M	196.87M	67.40M	126.49M	117.27M	73.21M
Operating Cash Flow	157.09M	212.07M	82.69M	143.13M	133.07M	83.48M
Investing Cash Flow	37.18M	42.64M	-15.52M	187.16M	13.96M	104.83M
Financing Cash Flow	-25.43M	-64.00M	-41.62M	-279.34M	-550.82M	-119.15M

Hospital Corporation of China Ltd Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 5.80
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3869, the sentiment is Negative. The current price of 5.8 is above the 20-day moving average (MA) of 3.96, above the 50-day MA of 4.65, and above the 200-day MA of 5.67, indicating a bearish trend. The MACD of -0.21 indicates Negative momentum. The RSI at 2.11 is Positive, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3869.

Hospital Corporation of China Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
0722	74 Outperform	HK$356.42M	4.98	4.28%	7.10%	-2.88%	-22.83%
3689	71 Outperform	HK$678.82M	3.30	5.29%	9.14%	0.47%	50.46%
3869	56 Neutral	HK$545.87M	5.00	31.63%	―	2.30%	―
1518	54 Neutral	HK$263.57M	-2.55	-25.22%	3.16%	-21.31%	-149.92%
1419	52 Neutral	HK$311.23M	4.11	3.54%	3.75%	9.07%	8.95%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
9906	51 Neutral	HK$936.00M	-275.87	1.85%	―	-13.22%	-69.35%